Jazz Pharmaceuticals PLC

JAZZ · Moat type: REGULIERUNG

MoatScore

3/10

Fair Value

131 USD

Margin of Safety

-80.7 %

Rating

SCHWACH

Jazz Pharmaceuticals is a pharmaceutical company specializing in sleep and oncology disorders, generating revenue primarily through patent-protected specialty medications—most notably sodium oxybate preparations for narcolepsy treatment as well as a growing oncology pipeline.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.